Gallbladder removal versus watchful waiting after bile duct stone removal in older adults
Official title: ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly
Run by Helsinki University Central Hospital · NCT07001423 · Data updated 2026-11-12
This trial tests whether immediate laparoscopic gallbladder removal or a wait-and-see approach is better for older patients after their common bile duct stones have been removed by ERCP.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Helsinki University Central Hospital Academic / other |
| Locations | 12 sites (Espoo and 11 other locations) |
| Status | Recruiting |
| Started | October 9, 2025 |
| Main results expected | August 31, 2031 |
| Study ends | August 31, 2032 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07001423 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are older adults (age ≥80, or 75–79 with a Charlson Comorbidity Index ≥2) who have had common bile duct stones cleared by ERCP and still have their gallbladder, and who can give informed consent.
✕Probably not a fit
Patients with acute cholecystitis, recent biliary pancreatitis or severe post-ERCP pancreatitis, chronic pancreatitis, bile duct pathology, widespread malignancy, or those unable to consent are not likely to benefit from this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial enrolls elderly patients whose common bile duct stones were successfully cleared by ERCP and randomizes 400 participants 1:1 to either laparoscopic cholecystectomy (done during the same admission or within two weeks) or a wait-and-see policy. The primary outcome is a composite of death, major postoperative complications, or recurrent biliary disease within one year after randomization. One planned interim safety analysis will be performed after 100 patients, with a strict stopping rule if a clear difference emerges (p<0.001). Eligible patients are generally aged ≥80, or 75–79 with higher comorbidity, and must have the gallbladder in place without active cholecystitis or significant pancreatitis.
Why it matters
Potential benefit: If successful, this could spare many older patients from an unnecessary operation while keeping rates of death, major complications, and recurrent biliary problems low.
How similar studies have gone: Previous smaller trials and observational studies have had mixed results, with some suggesting conservative management can be safe in selected elderly patients, but randomized evidence in this specific high-risk elderly group is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Common bile duct stones cleared after Endoscopic Retrograde Cholangio Pancreatography (ERCP) * Age \>= 80 years or age 75-79 years with a Charlson Comorbidity index \>=2 * gallbladder in situ Exclusion Criteria: * Acute Cholecystitis * Biliary Pancreatitis * Severe or moderately severe post-ERCP pancreatitis * Chronic pancreatitis * Bile duct pathology * Widespread malignancy * Unable to give consent
Where it's running
-
Helsinki University Hospital, Jorvi
Espoo, Finland Recruiting -
Helsinki University Hospital, Meilahti
Helsinki, Finland Recruiting -
Kanta-Häme Central Hospital
Hämeenlinna, Finland Not yet recruiting -
Pohjois-Karjala Central Hospital
Joensuu, Finland Not yet recruiting -
Keski-Suomi Central Hospital
Jyväskylä, Finland Not yet recruiting -
Kymenlaakso Central Hospital
Kotka, Finland Not yet recruiting
Show 6 more locations
-
Kuopio University Hospital
Kuopio, Finland Not yet recruiting -
Päijät-Häme Central Hospital
Lahti, Finland Not yet recruiting -
Oulu University Hospital
Oulu, Finland Not yet recruiting -
Tampere University Hospital
Tampere, Finland Not yet recruiting -
Turku University Hospital
Turku, Finland Not yet recruiting -
Vaasa Central Hospital
Vaasa, Finland Not yet recruiting
Study contacts
- Principal investigator: Panu Mentula, MD, PhD — Helsinki University Central Hospital
- Study coordinator: Panu Mentula, MD, PhD
- Email: panu.mentula@hus.fi
- Phone: +358504270183
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improvised retrieval bag vs direct gallbladder extraction in laparoscopic cholecystectomy
This trial tests whether using an improvised retrieval bag to remove the gallbladder during laparoscopic cholecystectomy is as safe and effective as removing it directly without a bag in adults with gallbladder stones.
-
Electrosurgical Patterns and Learning Curve in Laparoscopic Gallbladder Surgery
This study observes how surgeon experience relates to patterns of electrosurgery use during elective laparoscopic gallbladder removal to see if experience affects intraoperative difficulty.
-
Hyoscine Butylbromide During Transcystic Papillary Balloon Dilation for Choledocholithiasis
This study tests whether giving hyoscine butylbromide during laparoscopic transcystic papillary balloon dilation helps patients with common bile duct stones by making the procedure faster or easier.
-
Recto-Intercostal and External Oblique Intercostal Blocks for Pain after Laparoscopic Gallbladder Removal
This trial tests whether adding a recto-intercostal fascial plane block to an existing external oblique intercostal plane block provides better pain relief after laparoscopic cholecystectomy in adults.
-
Time to Lose Consciousness With Remimazolam vs Propofol for Anesthetic Induction
This study tests whether remimazolam changes the time to loss of consciousness compared with propofol for anesthesia induction in adults undergoing elective laparoscopic gallbladder removal.
-
Opiranserin plus acetaminophen vs NSAIDs plus acetaminophen after minimally invasive gallbladder removal
This trial tests whether opiranserin with acetaminophen works as well as NSAIDs with acetaminophen for pain after a minimally invasive cholecystectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.